Seibold Leonard K

Tan Nicholas E, Young Cara E Capitena, Seibold Leonard K

This review found trabecular bypass stents and canaloplasty effectively lower IOP and medication needs in glaucoma, with stents having more long-term data but canaloplasty offering similar efficacy without implant issues.

Mayeda Maxwell, Scott Anthony T, Young Cara Capitena, SooHoo Jeffrey R, Pantcheva Mina B, Patnaik Jennifer L et al.

This study found adding ECP to goniotomy didn't significantly improve IOP, but sustained medication reduction longer. Clinically, ECP may offer extended medication independence.

Stoner Ari M, Patnaik Jennifer L, Ertel Monica K, Capitena-Young Cara E, SooHoo Jeffrey R, Pantcheva Mina B et al.

Glaucoma patients show worse subjective and objective sleep quality, including longer sleep latency and more time awake after sleep onset, compared to controls, highlighting sleep disturbances in this population.

Bravetti Giorgio Enrico, Gillmann Kevin, Salinas Lauriane, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K et al.

KDB goniotomy for severe glaucoma significantly lowered IOP and medication use over 12 months, showing good safety. This offers a useful treatment option for high-risk eyes.

Miller Victoria J, Patnaik Jennifer L, Young Cara E Capitena, SooHoo Jeffrey R, Seibold Leonard K, Kahook Malik Y et al.

KDB goniotomy for uveitic glaucoma/OHT successfully lowered IOP and reduced medication use in some patients, offering a potential surgical option for these challenging cases.

Grover Davinder S, Kahook Malik Y, Seibold Leonard K, Singh Inder Paul, Ansari Husam, Butler Michelle R et al.

A study of the novel Ahmed ClearPath glaucoma device found it safely and effectively lowered IOP and medication use in refractory glaucoma, offering a new, potentially easier-to-implant treatment option.

Stoner Ari M, Capitena Young Cara E, SooHoo Jeffrey R, Pantcheva Mina B, Patnaik Jennifer L, Kahook Malik Y et al.

Comparing XEN and EX-PRESS devices for glaucoma, XEN offered fewer complications and clinic visits but had lower complete surgical success. This suggests a trade-off between safety/convenience and efficacy.

Becerril-Cazadero Roxana, Seibold Leonard K, Turati-Acosta Mauricio, Jiménez-Roman Jesus, Fabre-Miranda Karina, Han Ying et al.

Studying second Ahmed Glaucoma Valve implants for refractory glaucoma, researchers found they significantly reduce eye pressure for up to 18 months, offering a viable treatment option after initial valve failure.

Edwards Rebecca G, Vanderhoof Shawna, Palestine Alan, Seibold Leonard K

Daratumumab can cause bilateral acute secondary angle closure from choroidal effusions. Clinicians must recognize this rare, vision-threatening side effect for prompt intervention.

Gillmann Kevin, Young Cara C, Stanley Jordan, Seibold Leonard K, Hoskens Kirsten, Midha Neha et al.

This study found a contact lens sensor algorithm predicted fast visual field progression in glaucoma comparably to expert clinical assessment, offering a valuable new tool for risk stratification.

Young Cara E Capitena, Seibold Leonard K, Kahook Malik Y

Cataract surgery effectively lowers intraocular pressure in open-angle, angle-closure glaucoma, and ocular hypertension, often significantly reducing medication needs, especially in angle-closure and higher baseline pressures.

Miller Victoria J, Young Cara E Capitena, SooHoo Jeffrey R, Seibold Leonard K, Kahook Malik Y, Pecen Paula E et al.

KDB goniotomy effectively lowered IOP and reduced medications in uveitis-associated ocular hypertension/glaucoma patients, suggesting it's a safe, less invasive surgical option.

Epstein Rebecca S, Scott Anthony T, Capitena Young Cara E, Patnaik Jennifer L, Pantcheva Mina B, SooHoo Jeffrey R et al.

This study found no significant difference in angle visualization for ab interno glaucoma surgery whether performed before or after phacoemulsification, allowing surgeons to choose based on personal preference.

Salinas Lauriane, Chaudhary Ankita, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K, Dorairaj Syril K et al.

Ittoop Sabita M, Seibold Leonard K, Kahook Malik Y

This review highlights new drug delivery systems and MIGS devices in development, offering future glaucoma treatment options to improve adherence and customize care.

Marando Catherine M, Mansouri Kaweh, Kahook Malik Y, Seibold Leonard K

A wireless ocular sensor was well-tolerated by African American glaucoma patients for 24 hours, generating usable eye pressure profiles with higher readings during sleep, despite minor transient side effects.

Shah Avni A, Ling Jeanie, Nathan Niraj R, Kalhorn Ashton J, Chen Qingxia, Kammer Jeffrey A et al.

FLACS initially raises IOP, then significantly lowers it long-term, especially in glaucoma patients where reduction persists for at least 3 years, offering a potential therapeutic benefit.

Salinas Lauriane, Chaudhary Ankita, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K, Dorairaj Syril K et al.

Goniotomy with Kahook Dual Blade in severe glaucoma significantly lowered eye pressure and medication use at 6 months, offering a safe surgical alternative.

Capitena Young Cara E, Ammar David A, Seibold Leonard K, Pantcheva Mina B, SooHoo Jeffrey R, Kahook Malik Y

Trabecular bypass stents cause inflammatory and fibrotic TM changes, including cellular loss and fibrosis, suggesting a potential cause for device failure over time.

Manoharan Niranjan, Patnaik Jennifer L, Bonnell Levi N, SooHoo Jeffrey R, Pantcheva Mina B, Kahook Malik Y et al.

Glaucoma patients undergoing cataract surgery have a higher risk of refractive surprise and worse visual outcomes, impacting surgical planning and patient counseling.

Edmiston Anna M, SooHoo Jeffrey R, Seibold Leonard K, Kahook Malik Y, Palestine Alan G, Pantcheva Mina B

This study found postoperative inflammation after combined cataract surgery and ECP was common and linked to race (especially African Americans), but did not negatively impact visual acuity or IOP outcomes.

Greenwood Michael D, Seibold Leonard K, Radcliffe Nathan M, Dorairaj Syril K, Aref Ahmad A, Román Jesús Jimenez et al.

Single-use dual blade goniotomy with cataract surgery significantly lowered IOP and medication use in glaucoma patients for 6 months, offering an effective treatment option.

Bonnell Levi N, SooHoo Jeffrey R, Seibold Leonard K, Lynch Anne M, Wagner Brandie D, Davidson Richard S et al.

Tamsulosin users had a significantly higher risk of 1-day postoperative IOP spikes after cataract surgery. Clinically, identifying these patients preoperatively is crucial for managing and mitigating this risk.

Seibold Leonard K, Gamett Kevin M, Kennedy Jeffrey B, Mulvahill Matthew J, Kroehl Miranda E, SooHoo Jeffrey R et al.

Combined cataract surgery and iStent implantation effectively reduced IOP and medication burden in OAG patients with low baseline IOP, offering modest clinical benefits for some.

SooHoo Jeffrey R, Golas Liliya, Marando Catherine M, Seibold Leonard K, Pantcheva Mina B, Ramulu Pradeep Y et al.